| Page No 1 2 3 4 5 6 7 8 9 10 11 12 |
| Phrase | Consultant | Town | Special Interests |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, head and neck cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy for osteoarthritis, radiotherapy for tendinopathy, radiotherapy for non-melanoma skin cancer, radiotherapy for Dupuytren's contracture and Ledderhose disease, radiotherapy for plantar fasciitis and achilles tendinopathy, radiotherapy for keloid scarring, radiotherapy for bursitis | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lymphomas, gastrointestinal cancer, lung cancer, skin cancer, PET scanning in oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast radiotherapy, lung radiotherapy, skin radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, lung cancer, skin cancer, thyroid cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, breast cancer, upper and lower gastrointestinal cancer, systemic therapy Iodine 131 MIBG for neuroendocrine tumours, gastrointestinal chemoradiotherapy, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, skin cancer, radiotherapy, immunotherapy, salivary gland cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal cancer, head and neck cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, bladder tumours, stereotactic ablative radiotherapy, image-guided adaptive radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neurosurgery, brain tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, general radiotherapy, head and neck cancer, gynaecological cancer, lymphoma radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, acute oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, advanced radiotherapy techniques | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, thoracic and breast cancers, radiotherapy and chemotherapy, mesothelioma thymic tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, head and neck cancer, general oncology, radiotherapy and cyberknife | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, hepatobiliary oncology, thyroid cancer, upper gastrointestinal oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lymphoma, haematological oncology, head and neck cancer, thyroid cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper gastrointestinal cancers, CyberKnife, radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, central nervous system tumours, breast cancer, gamma knife, cyberknife, forbrain metastases, stereotactic radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer, haematological oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gastrointestinal cancer, lung cancer, skin cancer, thyroid cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology, external beam radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal cancer, radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, neuro-oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, gastrointestinal cancer, general radiotherapy, advanced radiotherapy techniques, cyberknife and gamma knife | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, intensity modulated radiotherapy - IMRT, stereotactic radiotherapy, central nervous system tumours, glioblastoma, glioma, skin cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, prostate cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, cyberknife - stereotactic radiotherapy, lymphoma, skin cancer, lung cancer and other lung tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lymphoma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, bladder cancer, prostate cancer, kidney cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma, skin cancer, CyberKnife, radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, skin cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate, bladder, penile and kidney cancers, testicular cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, radiotherapy, urological oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, gastrointestinal cancer, lung cancer, mesothelioma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, sarcoma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, gynaecological oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gynaecological cancer, prostate cancer, lung cancer, lymphoma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, breast cancer, ovarian cancer, urological cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper gastrointestinal cancer, colorectal cancer, gynaecological malignancies, head and neck cancers | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, neuro-oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, stereotactic radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, cancer immunology | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, PSMA PET imaging in prostate cancer, MR-linac based adaptive radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, immunotherapy, stereotactic ablative radiotherapy, chemotherapy, breast cancer, hormone therapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological malignancies - prostate cancer, external beam radiotherapy, high dose rate brachytherapy, hormone therapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, thyroid tumours | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, gynaecological brachytherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancers, skin cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, genito-urinary cancer, lung cancer, mesothelioma | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancer, skin cancer, squamous cell carcinoma, brachytherapy techniques | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, colorectal cancer, skull base tumours, proton therapy, immunotherapy, re-irradiation, complex recurrent cancers, gastrointestinal cancers, intensity modulated radiotherapy - IMRT, volumetric modulated arc therapy - VMAT, stereotactic radiosurgery and intraoperative radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, gastrointestinal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer, skin cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric radiotherapy | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer - Intensity Modulated Radiotherapy - IMRT, head and neck cancer -proton beam radiotherapy, olfactory neuroblastoma and sionnasal tumours are a special interest, stereotactic ablative body radiotherapy - SABR | clinical oncology | *Consultant(s)* | *Towns* | Medical oncology, clinical oncology, upper and lower gastrointestinal malignancies, urological cancers, oesophageal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, oesophagogastric cancer, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, bladder cancer, testicular cancer, germ cell tumours, prostate cancer | Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, neuro-oncology | cross-sectional oncology imaging | *Consultant(s)* | *Towns* | Head and neck radiology, cross-sectional oncology imaging | cutaneous oncology | *Consultant(s)* | *Towns* | Skin cancer and pigmented lesions, drug toxicities and reactions, general dermatology, cutaneous oncology, eczema, psoriasis, acne, rosacea, benign skin lesions, inflammatory skin rashes | dermatological oncology | *Consultant(s)* | *Towns* | Clinical oncology, dermatological oncology, melanoma, lymphoma, brachytherapy, urological oncology | dermatological oncology | *Consultant(s)* | *Towns* | Psoriasis, cosmetic dermatology, dermatological oncology, dermatitis, acne, alopecia, vitiligo, rosacea, urticaria | Dermatological oncology | *Consultant(s)* | *Towns* | Dermatological oncology | endocrine oncology | *Consultant(s)* | *Towns* | Neuroendocrinology, pituitary tumours, general endocrinology, endocrine oncology | gastrointestinal oncology | *Consultant(s)* | *Towns* | Medical oncology, pancreatic cancer, gastrointestinal oncology | gastrointestinal oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, lymphoma, colorectal cancer, oesophagogastric cancer, pancreatic cancer, advanced bowel cancer | gastrointestinal oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, hepatobiliary cancer | gastrointestinal oncology | *Consultant(s)* | *Towns* | Clinical oncology, gastrointestinal oncology | gastrointestinal oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, oligometastatic disease, cancer of unknown primary | gastrointestinal oncology | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, carcinoma of unknown primary, acute oncology | | Page No 1 2 3 4 5 6 7 8 9 10 11 12 |
